Rathbones Group’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-77,086
Closed -$1.47M 669
2026
Q1
$1.47M Hold
77,086
0.01% 322
2025
Q4
$1.86M Hold
77,086
0.01% 303
2025
Q3
$1.97M Hold
77,086
0.01% 290
2025
Q2
$1.66M Hold
77,086
0.01% 304
2025
Q1
$1.76M Hold
77,086
0.01% 289
2024
Q4
$2M Hold
77,086
0.01% 280
2024
Q3
$1.93M Sell
77,086
-5,000
-6% -$118K 0.01% 279
2024
Q2
$1.76M Hold
82,086
0.01% 275
2024
Q1
$1.52M Sell
82,086
-6,000
-7% -$105K 0.01% 282
2023
Q4
$1.43M Hold
88,086
0.01% 283
2023
Q3
$1.22M Buy
+88,086
New +$1.39M 0.01% 290
2022
Q1
Sell
-8,668
Closed -$323K 422
2021
Q4
$323K Hold
8,668
﹤0.01% 353
2021
Q3
$367K Hold
8,668
﹤0.01% 334
2021
Q2
$386K Sell
8,668
-350
-4% -$12.3K ﹤0.01% 335
2021
Q1
$325K Hold
9,018
﹤0.01% 334
2020
Q4
$360K Sell
9,018
-1,621
-15% -$55.3K 0.01% 309
2020
Q3
$308K Hold
10,639
0.01% 307
2020
Q2
$174K Sell
10,639
-1,450
-12% -$20K ﹤0.01% 333
2020
Q1
$115K Sell
12,089
-1,856
-13% -$25.5K ﹤0.01% 299
2019
Q4
$226K Sell
13,945
-550
-4% -$8.94K 0.01% 299
2019
Q3
$241K Hold
14,495
0.01% 293
2019
Q2
$246K Hold
14,495
0.01% 280
2019
Q1
$259K Hold
14,495
0.01% 269
2018
Q4
$174K Buy
+14,495
New +$173K 0.01% 291

Other funds holding BLFS

Rathbones Group's BLFS Position: Q2 2026 in Review

Rathbones Group sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 77,086 shares — an estimated $1.47M sold.

Rathbones Group first reported a position in BLFS in Q4 2018 and held it in 24 quarters. The position peaked at $2M in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Rathbones Group reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • Rathbones Group sold 77,086 BioLife Solutions shares in Q2 2026, an estimated $1.47M.
  • Rathbones Group first reported a position in BioLife Solutions in Q4 2018 and held it in 24 quarters.
  • Rathbones Group's BioLife Solutions position peaked at $2M in Q4 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.